Background
The Boehringer Ingelheim (BI) group is one of the world’s leading pharmaceutical companies, which has focused on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
The Respimat® Soft Mist™ Inhaler is a next-generation inhaler that generates a slow-moving soft mist which is easy to inhale and delivers the drug effectively and reliably into the lungs of patients with asthma or other pulmonary diseases. It is mechanically driven and therefore does not rely on harmful aerosol propellants for atomization. The medication is stored and introduced into the inhaler via a cartridge which consists of a plastic container enclosed in an aluminum shell.